Dow Up 0.12% Nasdaq Up 1.35%

Oncothyreon Inc (ONTY)

-NasdaqGS
1.73 0.02(1.17%) Oct 20, 4:00PM EDT
|After Hours : 1.73 0.00 (0.00%) Oct 20, 5:02PM EDT
Prev Close:1.71
Open:1.69
Bid:1.60 x 700
Ask:2.65 x 300
1y Target Est:3.50
Beta:1.63
Next Earnings Date:N/A
Day's Range:1.69 - 1.80
52wk Range:1.67 - 4.08
Volume:595,004
Avg Vol (3m):744,355
Market Cap:122.50M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ONTYUp 1.17%122.50M
GSK104.75B
RHHBY243.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback